Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

Marja-Riitta Taskinen, J. Rosenstock, I. Tamminen, R. Kubiak, S. Patel, K. A. Dugi, H. -J. Woerle

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalDiabetes, obesity and metabolism
Volume13
Issue number1
Pages (from-to)65-74
Number of pages10
ISSN1462-8902
DOIs
Publication statusPublished - 2011
MoE publication typeA1 Journal article-refereed

Fields of Science

  • combination therapy
  • dipeptidyl peptidase-4
  • DPP-IV inhibitor
  • glycaemic control
  • linagliptin
  • metformin
  • metformin add-on
  • type 2 diabetes
  • DIPEPTIDYL PEPTIDASE-4 INHIBITOR
  • GLUCAGON-LIKE PEPTIDE-1
  • GLYCEMIC CONTROL
  • MELLITUS
  • VILDAGLIPTIN
  • MONOTHERAPY
  • PHARMACOKINETICS
  • PHARMACODYNAMICS
  • TOLERABILITY
  • MANAGEMENT

Cite this